glp 1 anaesthesia GLP-1 medications safe to continue before surgery in patients with diabetes and obesity GLP-1s, Gut Motility & IBS
Description
GLP-1 receptor agonists represent one of the most studied medication classes in modern medicine, with over a decade of clinical trial data supporting their effectiveness for sustainable weight loss and improved metabolic markers
Tirzepatide displayed an unprecedented glucose and body weight lowering potential, presenting also with the ability to increase insulin sensitivity, reduce systolic blood pressure and inflammation and ameliorate dyslipidemia, particularly by reducing triglycerides levels
Understanding these conflicts helps ensure safe, successful treatment with semaglutide or tirzepatide
Background Inflammation is a common pathological phenomenon of osteoarthritis (OA)
GLP-1 Is Not JUST a Weight-Loss Drug
Supports a healthy inflammatory response with naturally-derived ingredients*
